Search

everythinglearnresearchcommunity

for

Search:↓

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Dystonia may be part of PAS-4 and linked to immune issues.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Confirm testosterone levels with advanced tests to avoid unnecessary procedures.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Autoimmune reactions may cause both alopecia areata and HAM.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Bullous pemphigoid can look like erythema multiforme, so awareness is needed for proper treatment.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

Alopecia areata and polymyalgia rheumatica may be linked autoimmune conditions.

Antibody treatments show promise for hair loss but need more research.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.